PROFUND ADVISORS LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,787,659
+27.4%
41,039
+5.7%
0.10%
+32.0%
Q2 2023$1,403,072
+19.7%
38,834
+23.2%
0.08%
+4.2%
Q1 2023$1,172,174
+347.6%
31,527
+445.4%
0.07%
+323.5%
Q4 2022$261,892
-31.3%
5,780
+5.9%
0.02%
-37.0%
Q3 2022$381,000
-0.5%
5,457
-4.4%
0.03%
+12.5%
Q2 2022$383,000
-24.8%
5,711
-7.7%
0.02%
+14.3%
Q1 2022$509,000
-49.1%
6,190
-9.2%
0.02%
-36.4%
Q4 2021$1,000,000
-24.1%
6,816
-8.5%
0.03%
-25.0%
Q3 2021$1,318,000
+488.4%
7,450
+469.6%
0.04%
+388.9%
Q1 2021$224,000
+12.0%
1,308
+43.4%
0.01%0.0%
Q4 2020$200,0009120.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders